CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-28 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −710 | $70.84 | $50K | 0 |
| 2023-06-28 | Malecek Michael J Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 105,000 | ||
| 2023-06-20 | Walker Karin L Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $15.04 | $75K | 5,000 |
| 2023-06-20 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −2,000 | $67.88 | $136K | 3,000 |
| 2023-06-20 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −2,471 | $69.49 | $172K | 529 |
| 2023-06-20 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −529 | $69.99 | $37K | 0 |
| 2023-06-20 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 15,481 | ||
| 2023-06-16 | Garren Hideki Chief Medical Officer | Option exercise 10b5-1 | +7,331 | $24.90 | $183K | 7,331 |
| 2023-06-16 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −7,331 | $74.00 | $542K | 0 |
| 2023-06-16 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,331 | 198,000 | ||
| 2023-06-14 | Smith Brandon S. Chief Operating Officer | Option exercise 10b5-1 | +5,333 | $11.12 | $59K | 5,333 |
| 2023-06-14 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −1,098 | $72.52 | $80K | 4,235 |
| 2023-06-14 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −1,914 | $73.35 | $140K | 2,321 |
| 2023-06-14 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −959 | $74.69 | $72K | 1,362 |
| 2023-06-14 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −1,362 | $75.56 | $103K | 0 |
| 2023-06-14 | Smith Brandon S. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,333 | 234,667 | ||
| 2023-06-14 | Garren Hideki Chief Medical Officer | Option exercise 10b5-1 | +4,669 | $24.90 | $116K | 4,669 |
| 2023-06-14 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −509 | $72.45 | $37K | 4,160 |
| 2023-06-14 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −971 | $73.31 | $71K | 3,189 |
| 2023-06-14 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −2,534 | $74.59 | $189K | 655 |
Page 12 of 28 · 555 trades